BIOMARKERS AND METHODS FOR PROGRESSION PREDICTION FOR CHRONIC KIDNEY DISEASE

Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumi...

Full description

Saved in:
Bibliographic Details
Main Authors MAGNONE, MARIA CHIARA, DUCHATEAU-NGUYEN, GUILLEMETTE, FORMENTINI, IVAN, LANGEN, HANNO, SCHINDLER, THOMAS, JU, WENJU, BOBADILLA, MARIA, BADI, LAURA, SOLIER, CORINNE, KRETZLER, MATTHIAS, ESSIOUX, LAURENT, DURAN PACHECO, GONZALO CHRISTIAN, NAIR, VIJI, THIER, MARTINA
Format Patent
LanguageEnglish
French
Published 07.05.2015
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio. La présente invention concerne des biomarqueurs et des procédés d'identification d'un risque accru de progression d'une néphropathie chronique (CKD), ou de surveillance d'une néphropathie chronique, comprenant la détection du niveau d'un ou de plusieurs des NTpro BNP, EGF, Apo H, GDF-15, et rapport albumine/créatinine.
Bibliography:Application Number: CA20142929444